rs142517355

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6BP7BS2

The NM_001161748.2(LIM2):​c.57G>A​(p.Leu19Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00106 in 1,614,188 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00074 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 5 hom. )

Consequence

LIM2
NM_001161748.2 synonymous

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 1.81

Publications

3 publications found
Variant links:
Genes affected
LIM2 (HGNC:6610): (lens intrinsic membrane protein 2) This gene encodes an eye lens-specific protein found at the junctions of lens fiber cells, where it may contribute to cell junctional organization. It acts as a receptor for calmodulin, and may play an important role in both lens development and cataractogenesis. Mutations in this gene have been associated with cataract formation. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Sep 2009]
LIM2-AS1 (HGNC:56004): (LIM2 and SIGLEC10 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.37).
BP6
Variant 19-51387387-C-T is Benign according to our data. Variant chr19-51387387-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 541269.
BP7
Synonymous conserved (PhyloP=1.81 with no splicing effect.
BS2
High Homozygotes in GnomAdExome4 at 5 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LIM2NM_001161748.2 linkc.57G>A p.Leu19Leu synonymous_variant Exon 2 of 5 ENST00000596399.2 NP_001155220.1 P55344-1
LIM2NM_030657.4 linkc.57G>A p.Leu19Leu synonymous_variant Exon 2 of 5 NP_085915.2 P55344-2
LIM2-AS1XR_002958397.2 linkn.*16C>T downstream_gene_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LIM2ENST00000596399.2 linkc.57G>A p.Leu19Leu synonymous_variant Exon 2 of 5 1 NM_001161748.2 ENSP00000472090.2 P55344-1
LIM2ENST00000221973.7 linkc.57G>A p.Leu19Leu synonymous_variant Exon 2 of 5 1 ENSP00000221973.2 P55344-2
LIM2-AS1ENST00000738639.1 linkn.303C>T non_coding_transcript_exon_variant Exon 1 of 3
LIM2-AS1ENST00000738640.1 linkn.188C>T non_coding_transcript_exon_variant Exon 2 of 3

Frequencies

GnomAD3 genomes
AF:
0.000742
AC:
113
AN:
152228
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00751
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000941
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00101
AC:
255
AN:
251268
AF XY:
0.000920
show subpopulations
Gnomad AFR exome
AF:
0.000123
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000595
Gnomad EAS exome
AF:
0.00772
Gnomad FIN exome
AF:
0.0000924
Gnomad NFE exome
AF:
0.000801
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.00110
AC:
1601
AN:
1461842
Hom.:
5
Cov.:
33
AF XY:
0.00107
AC XY:
776
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.0000896
AC:
3
AN:
33478
American (AMR)
AF:
0.0000224
AC:
1
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000421
AC:
11
AN:
26136
East Asian (EAS)
AF:
0.0145
AC:
575
AN:
39700
South Asian (SAS)
AF:
0.000371
AC:
32
AN:
86258
European-Finnish (FIN)
AF:
0.0000937
AC:
5
AN:
53380
Middle Eastern (MID)
AF:
0.000868
AC:
5
AN:
5762
European-Non Finnish (NFE)
AF:
0.000841
AC:
935
AN:
1112008
Other (OTH)
AF:
0.000563
AC:
34
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
107
214
322
429
536
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000742
AC:
113
AN:
152346
Hom.:
0
Cov.:
32
AF XY:
0.000725
AC XY:
54
AN XY:
74506
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41590
American (AMR)
AF:
0.000131
AC:
2
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00753
AC:
39
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000941
AC:
64
AN:
68030
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
6
12
17
23
29
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000732
Hom.:
0
Bravo
AF:
0.000854
Asia WGS
AF:
0.00202
AC:
7
AN:
3478
EpiCase
AF:
0.00115
EpiControl
AF:
0.000652

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Cataract 19 multiple types Uncertain:1Benign:1
May 29, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

Inborn genetic diseases Benign:1
Dec 27, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

LIM2-related disorder Benign:1
Aug 28, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
May 19, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.37
CADD
Benign
12
DANN
Benign
0.82
PhyloP100
1.8
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142517355; hg19: chr19-51890641; API